Application of the United States acute heart failure risk prediction model in Japanese patients; analysis from a contemporary multicenter registry.
暂无分享,去创建一个
K. Fukuda | Y. Shiraishi | S. Kohsaka | A. Goda | A. Mizuno | T. Yoshikawa | J. Makino | T. Inohara | Y. Izumi | Mayuko Yagawa | M. Yagawa
[1] Mark D. Huffman,et al. Executive Summary: Heart Disease and Stroke Statistics—2015 Update A Report From the American Heart Association , 2011, Circulation.
[2] C. Phillips,et al. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. , 2007, Journal of the American College of Cardiology.
[3] C. Hamm,et al. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine , 2005, Heart.
[4] Luigi Tavazzi,et al. Acute Heart Failure Syndromes: Current State and Framework for Future Research , 2005, Circulation.
[5] W John Boscardin,et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. , 2005, JAMA.
[6] Eliot Corday,et al. Overview of Acutely Decompensated Congestive Heart Failure (ADHF): A Report from the ADHERE Registry , 2005, Heart Failure Reviews.
[7] C. O'connor,et al. The problem of decompensated heart failure: nomenclature, classification, and risk stratification. , 2003, American heart journal.
[8] A. Maisel,et al. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? , 2002, Circulation.